Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1999 1
2010 1
2011 2
2013 3
2014 2
2015 3
2016 3
2017 2
2019 1
2020 2
2021 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
DYT1 Early-Onset Isolated Dystonia.
Ozelius L, Lubarr N. Ozelius L, et al. Among authors: lubarr n. 1999 Apr 14 [updated 2016 Nov 17]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 1999 Apr 14 [updated 2016 Nov 17]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 20301665 Free Books & Documents. Review.
Milestones in dystonia.
Ozelius LJ, Lubarr N, Bressman SB. Ozelius LJ, et al. Among authors: lubarr n. Mov Disord. 2011 May;26(6):1106-26. doi: 10.1002/mds.23775. Mov Disord. 2011. PMID: 21626555 Review.
DYT1 dystonia increases risk taking in humans.
Arkadir D, Radulescu A, Raymond D, Lubarr N, Bressman SB, Mazzoni P, Niv Y. Arkadir D, et al. Among authors: lubarr n. Elife. 2016 Jun 1;5:e14155. doi: 10.7554/eLife.14155. Elife. 2016. PMID: 27249418 Free PMC article.
Treatment of generalized dystonia.
Lubarr N, Bressman S. Lubarr N, et al. Curr Treat Options Neurol. 2011 Jun;13(3):274-89. doi: 10.1007/s11940-011-0122-0. Curr Treat Options Neurol. 2011. PMID: 21455718
Worldwide barriers to genetic testing for movement disorders.
Gatto EM, Walker RH, Gonzalez C, Cesarini M, Cossu G, Stephen CD, Balint B, Rodríguez-Violante M, Jankovic J, Morgante F, Jinnah HA; Rare Movement Disorders Study Group of the International Parkinson Disease, Movement Disorders Society. Gatto EM, et al. Eur J Neurol. 2021 Jun;28(6):1901-1909. doi: 10.1111/ene.14826. Epub 2021 Apr 9. Eur J Neurol. 2021. PMID: 33730413
Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance.
San Luciano M, Tanner CM, Meng C, Marras C, Goldman SM, Lang AE, Tolosa E, Schüle B, Langston JW, Brice A, Corvol JC, Goldwurm S, Klein C, Brockman S, Berg D, Brockmann K, Ferreira JJ, Tazir M, Mellick GD, Sue CM, Hasegawa K, Tan EK, Bressman S, Saunders-Pullman R; Michael J. Fox Foundation LRRK2 Cohort Consortium. San Luciano M, et al. Mov Disord. 2020 Oct;35(10):1755-1764. doi: 10.1002/mds.28189. Epub 2020 Jul 14. Mov Disord. 2020. PMID: 32662532 Free PMC article.
Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome.
Wang JY, Trivedi AM, Carrillo NR, Yang J, Schneider A, Giulivi C, Adams P, Tassone F, Kim K, Rivera SM, Lubarr N, Wu CY, Irwin RW, Brinton RD, Olichney JM, Rogawski MA, Hagerman RJ. Wang JY, et al. Among authors: lubarr n. Neurotherapeutics. 2017 Oct;14(4):1073-1083. doi: 10.1007/s13311-017-0555-6. Neurotherapeutics. 2017. PMID: 28707277 Free PMC article. Clinical Trial.
The minimal clinically important change in the motor section of the Burke-Fahn-Marsden Dystonia Rating Scale for generalized dystonia: Results from deep brain stimulation.
Esther Cubo, Miravite J, Calvo S, Cooper K, Raymond D, Ooi HY, Lubarr N, Bressman S, Saunders-Pullman R. Esther Cubo, et al. Among authors: lubarr n. Parkinsonism Relat Disord. 2021 Dec;93:85-88. doi: 10.1016/j.parkreldis.2021.11.016. Epub 2021 Nov 19. Parkinsonism Relat Disord. 2021. PMID: 34856447
Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease.
Alcalay RN, Mejia-Santana H, Mirelman A, Saunders-Pullman R, Raymond D, Palmese C, Caccappolo E, Ozelius L, Orr-Urtreger A, Clark L, Giladi N, Bressman S, Marder K; LRRK2 Ashkenazi Jewish Consortium. Alcalay RN, et al. Parkinsonism Relat Disord. 2015 Feb;21(2):106-10. doi: 10.1016/j.parkreldis.2014.09.033. Epub 2014 Nov 20. Parkinsonism Relat Disord. 2015. PMID: 25434972 Free PMC article.
20 results